Harmony Biosciences Holdings, Inc. HRMY Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $752.5M+66.1% | $453M+45.4% | $311.66M+27.8% | $243.78M+4.0% | ||
| $22.84M+61.0% | $14.19M-66.1% | $41.8M-47.3% | $79.33M— | ||
| $396.39M+21.1% | $327.41M+27.0% | $257.79M+30.4% | $197.76M+61.0% | ||
| $5.36M-25.6% | $7.2M+34.2% | $5.36M+24.8% | $4.3M-3.0% | ||
| $16.01M+16.8% | $13.71M+9.1% | $12.57M+34.5% | $9.35M+22.4% | ||
| $907.01M+56.6% | $579.25M+28.4% | $451.07M+12.7% | $400.29M+40.7% | ||
| $89.42M-21.1% | $113.26M-17.4% | $137.11M-14.8% | $160.95M+11.8% | ||
| $18.37M+148% | $7.41M+17.7% | $6.3M+125% | $2.8M-20.4% | ||
| $107.13M-1.6% | $108.87M+50.9% | $72.17M+220% | $22.57M— | ||
| $364.62M-13.2% | $419.95M+16.5% | $360.38M+31.7% | $273.59M+83.6% | ||
| $1.27B+27.3% | $999.2M+23.1% | $811.45M+20.4% | $673.87M+55.5% | ||
| $17.69M+28.7% | $13.74M-22.5% | $17.73M+368% | $3.79M+278% | ||
| $18.44M-1.8% | $18.78M-20.9% | $23.75M+106% | $11.53M+748% | ||
| $20M+23.1% | $16.25M+8.3% | $15M+650% | $2M0.0% | ||
| $1.07M-18.6% | $1.32M-8.3% | $1.44M-11.0% | $1.61M+5.7% | ||
| $252.13M+44.0% | $175.08M+6.9% | $163.78M+108% | $78.88M+46.7% | ||
| $143.66M-11.9% | $163.02M-8.7% | $178.57M-5.8% | $189.65M-0.2% | ||
| $5.59M+161% | $2.14M-15.0% | $2.52M-2.7% | $2.59M-31.1% | ||
| $5.62M+189% | $1.95M-7.7% | $2.11M-15.7% | $2.5M-21.3% | ||
| $149.28M-9.5% | $164.96M-8.7% | $180.68M-6.0% | $192.15M-0.5% | ||
| $401.41M+18.0% | $340.05M-1.3% | $344.46M+27.1% | $271.03M+9.8% | ||
| $1K0.0% | $1K0.0% | $1K0.0% | $1K0.0% | ||
| $708.97M+7.9% | $656.87M+7.6% | $610.27M-9.6% | $675.12M+5.5% | ||
| $160.9M+7,161% | $2.22M+102% | -$143.28M+47.3% | -$272.13M+40.0% | ||
| $346K+424% | $66K+3,200% | $2K+101% | -$151K— | ||
| $870.22M+32.0% | $659.16M+41.1% | $466.99M+15.9% | $402.84M+116% | ||
| $1.27B+27.3% | $999.2M+23.1% | $811.45M+20.4% | $673.87M+55.5% | ||
| $13.52M+66.4% | $8.12M+46.7% | $5.54M-37.0% | $8.79M+173% | ||
| $18.37M+148% | $7.41M+17.7% | $6.3M+125% | $2.8M-20.4% | ||
| $149.7M-21.4% | $190.4M+32.1% | $144.16M+67.7% | $85.94M— | ||
| $89.42M-21.1% | $113.26M-17.4% | $137.11M-14.8% | $160.95M+11.8% | ||
| $107.13M-1.6% | $108.87M+50.9% | $72.17M+220% | $22.57M— | ||
| $18.37M+148% | $7.41M+17.7% | $6.3M+125% | $2.8M-20.4% | ||
| $22.84M+61.0% | $14.19M-66.1% | $41.8M-47.3% | $79.33M— | ||
| $18.37M+148% | $7.41M+17.7% | $6.3M+125% | $2.8M-20.4% | ||
| $18.44M-1.8% | $18.78M-20.9% | $23.75M+106% | $11.53M— | ||
| $191.04M— | —— | —— | $59.94M+48.9% | ||
| $191.04M— | —— | —— | $59.94M+48.9% | ||
| $18.44M-1.8% | $18.78M-20.9% | $23.75M+106% | $11.53M— | ||
| $4.96M-12.6% | $5.67M-27.4% | $7.81M+381% | $1.62M+19.4% | ||
| $169.25M-6.7% | $181.41M-7.5% | $196.09M+1.0% | $194.24M-0.8% | ||
| $708.97M+7.9% | $656.87M+7.6% | $610.27M-9.6% | $675.12M+5.5% | ||
| $1K0.0% | $1K0.0% | $1K0.0% | $1K0.0% | ||
| $16.01M+16.8% | $13.71M+9.1% | $12.57M+34.5% | $9.35M+22.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can Harmony Biosciences Holdings, Inc. cover its short-term obligations?
- Its current ratio is 3.58 — current assets exceed current liabilities.
- Where does Harmony Biosciences Holdings, Inc.'s balance sheet data come from?
- Every line is extracted from Harmony Biosciences Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.